Correlation between 18F-FDG PET/CT intra-tumor metabolic heterogeneity parameters and KRAS mutation in colorectal cancer-Reference-Cited by-同舟云学术

Correlation between 18F-FDG PET/CT intra-tumor metabolic heterogeneity parameters and KRAS mutation in colorectal cancer

Published:2022-02-09 Issue:4 Volume:47 Page:1255-1264
ISSN:2366-0058
Container-title:Abdominal Radiology
language:en
Short-container-title:Abdom Radiol

Author:

Liu Xin,Wang Shi-Cun,Ni Ming,Xie Qiang,Zhang Yi-Fan,Lv Wei-Fu,Geng Guang-Yong^ORCID

Funder

National and provincial key specialty construction plan

Anhui Provincial Key Research and Development Program Project, China

Anhui Provincial Natural Science Foundation for Youths, China

Publisher

Springer Science and Business Media LLC

Subject

Urology,Gastroenterology,Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Link

https://link.springer.com/content/pdf/10.1007/s00261-022-03432-5.pdf

Reference27 articles.

1. Sung H, Ferlay J, Siegel RL, et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209-249. https://doi.org/10.3322/caac.21660

2. Stewart BC, Wild CP (2019) World cancer report 2014. Available at: http://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports/World-Cancer-Report-2014. Accessed 8 June 2019

3. National Health Commission Of The People’s Republic Of China (2020) National guidelines for diagnosis and treatment of colorectal cancer 2020 in China (English version). Chin J Cancer Res 32(4):415-445. https://doi.org/10.21147/j.issn.1000-9604.2020.04.01

4. Cook AD, Single R, McCahill LE (2005) Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol 12(8):637-645. https://doi.org/10.1245/ASO.2005.06.012

5. Karapetis CS, Khambata-Ford S, Jonker DJ et al (2008) K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med 359(17):1757-1765. https://doi.org/10.1056/NEJMoa0804385

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into metabolic heterogeneity of colorectal cancer gained from fluorescence lifetime imaging;eLife;2024-08-28

2. Insights into metabolic heterogeneity of colorectal cancer gained from fluorescence lifetime imaging;eLife;2024-08-28

3. Metabolic heterogeneity of colorectal cancer as a prognostic factor: insights gained from fluorescence lifetime imaging;2024-08-06

4. Metabolic heterogeneity of colorectal cancer as a prognostic factor: insights gained from fluorescence lifetime imaging;2024-05-01

5. Relationship of FDG PET/CT imaging features with tumor immune microenvironment and prognosis in colorectal cancer: a retrospective study;Cancer Imaging;2024-04-16